CN106138712A - One is used for treating myelitic medicine - Google Patents
One is used for treating myelitic medicine Download PDFInfo
- Publication number
- CN106138712A CN106138712A CN201610661145.5A CN201610661145A CN106138712A CN 106138712 A CN106138712 A CN 106138712A CN 201610661145 A CN201610661145 A CN 201610661145A CN 106138712 A CN106138712 A CN 106138712A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix astragali
- atractylodis macrocephalae
- flos lonicerae
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
The present invention relates to a kind of for treating myelitic medicine, it is to be prepared from by the raw medicinal material of following weight proportion: Rhizoma Polygonati Odorati 12 parts, Fructus Corni 7 parts, the Radix Astragali 12 parts, Semen Bauhiniae championii 10 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Flos Lonicerae maackii 12 parts, Caulis Trachelospermi 10 parts, CORTEX ACANTHOPANACIS 8 parts.The present invention uses: Rhizoma Polygonati Odorati nourishing YIN and moistening the lung；Fructus Corni liver and kidney tonifying；Radix Astragali benefiting QI and nourishing blood；Semen Bauhiniae championii promoting the circulation of QI to relieve pain, blood circulation promoting and blood stasis dispelling；Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI；Flos Lonicerae maackii heat-clearing and toxic substances removing；Caulis Trachelospermi promoting blood circulation to remove obstruction in the collateral, removing toxic substances and promoting subsidence of swelling；CORTEX ACANTHOPANACIS invigorating the liver and kidney, bone and muscle strengthening, arteries and veins of invigorating blood circulation.All medicines share, and play nourishing YIN and moistening the lung, liver and kidney tonifying, invigorating the spleen and benefiting QI, replenishing and activating blood, effect of strong muscles and bones altogether.Clinical trial certificate, the present invention can safely and effectively treat myelitis.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of for treating myelitic medicine.
Background technology
Myelitis is to infect or toxin is invaded and disease caused by spinal cord.Because the pathological changes at spinal cord is often transverse, therefore also known as
Transverse myelitis.Acute myelitis caused by virus infection mostly occurs person between twenty and fifty, and asexuality difference is dispersed in morbidity, onset
More anxious.There is slight prodrome, such as the symptom of low grade fever, general malaise or upper respiratory tract infection more.
Symptom: before sick, often there are upper respiratory tract or intestinal infection medical history, a vaccination history a couple of days or 1～2 week, or suffer from cold,
Overwork, bear a heavy burden, the inducement such as sprain.Primary disease morbidity is hurried.Within a few hours to 1～2 day, complete paraplegia can occur.Part is sick
People has back pain, zonesthesia, numb limbs and tense tendons, a pioneer's symptom such as unable at premorbid, and in a couple of days to ten the most gradually
It is developed to panplegia.
Myelitic clinical symptoms can be according to its diseased region, the difference of scope, and difference.Due to breast myelomere section
Longer, and some sections blood supply is poor, pathological changes Chang Yi involves breast marrow.Its onset symptoms Chang Weishuan numbness of lower limbs, unable, pathological changes
Corresponding site backache, zonesthesia, or see dysuria.After 2～3 days, PD to peak, the complete of below lesion levels occurs
Full property paralysis, anesthesia, hypohidrosis or lossless network two just retention.
Morbidity in early days, is in the spinal shock stage, limbs power flaccid paralysis, the most so-called collapses from physical exhaustion.Through 2～4
The time in week, limbs gradually become spastic paralysis, that is so-called hard paralysis, and micturition problems is also transferred to urinary incontinence by urine retention.
When pathological changes involves neck marrow, quadriplegia can occur.If having influence on neck section tumor of spinal cord (more than C4), it is also possible to dyspnea occurs.
Cervical enlargement myelitis can occur that double upper limb collapses from physical exhaustion, and double lower limb are the most paralysed.Diseased region is when waist marrow, and lower limb are flaccid paralysis
Paralysis, the most visible amyotrophy.Pathological changes is when dice marrow, and disturbance of sphincter is obvious, and without significantly paralysis.It addition, also one
Planting ascending myelitis, this type myelitis onset is hurried, and pathological changes can develop the most from bottom to top, often in 1～2 day, even
In a few hours, the state of an illness peaks.Quadriplegia, dysphagia, slurred speech, dyspnea, even paralysis of respiratory muscle occur
And it is dead.
Sign: lesions visible transverse spinal cord lesion below horizontal.Occur that completeness paralysis motorica, deep, superficial sensibility disappear
Lose, hypohidrosis or lossless and sphincter dysfunction.Shock stage quadriplegia is flaccid paralysis, and muscular tension is low, tendon reflex low or
Disappearing, pathology is levied feminine gender, abdominal reflex and cremasteric reflex and is disappeared；Convalescent period hypermyotonia, tendon hyperreflexia, pathology levies sun
Property.
Myelitis is mostly the autoimmune response caused by virus infection, or because of the ridge caused by the reasons such as poisoning, allergy
Marrow inflammation.Its cause of disease mainly has influenza virus, varicella zoster virus, rabies virus, poliovirus etc., have in recent years by
Hepatitis virus is caused myelitic report.Still some patient is agnogenio, but often has some upper respiratory tract infection before disease
Symptom.Most commonly seen with transection myelitis clinically, its pathological changes, with breast Duan Weizhu, is secondly cervical part of esophagus, and waist section and sacrum section are sick
Become the most rare.Show as myeleterosis quadriplegia below horizontal, anesthesia and bladder, rectal dysfunction.
Treatment
One, general treatment
1. acute stage, should be lain up, given the diet rich in heat and vitamin.Or give ATP, coenzyme A, adenosine, born of the same parents two phosphorus
The medicines such as choline, to promote the recovery of function of nervous system.A small amount of repeatedly infusion Healthy People fresh plasma also contributes to improve patient's
Immunologic function, is of value to prevention and infects and recover.
2. duty is stood up, and keeps skin clean, is dried, and notes massaging pressurized position, prevents the generation of decubital ulcer.
3. urine retention severe patient needs urethral catheterization, can indwelling sterilized catheter, within every 3～4 hours, put urine 1 time, in case contracture of bladder.
It is noted that prevent urinary system infection during indwelling catheter.To difficult defecation person, should cleansing enema in time, or select laxative.
Two, adrenocortical hormone
It is now recognized that myelitis is relevant with autoimmune, adrenocortical hormones in treating can be tried out.With hydrocortisone every day 5～
10mg/kg, addition 5～the 10% molten iv drip of tucking in of glucose, every day 1 time.Take the circumstances into consideration decrement after 1～2 week, or change prednisone into
Oral, and gradually subtract and stop.
Three, other therapies
1. plasmapheresis: the harmful substances such as the repeats itself antibody in patient's blood plasma and immune complex can be removed, to critical illness
People can relief of symptoms, hormone therapy nonresponder is likely to prove effective.General every day 1 time, 7 days is a course for the treatment of.
2. ultraviolet irradiation and oxygenated blood auto infusion: take patient oneself whole blood 150～200m1, after oxygenation ultraviolet irradiates
Feed back.1～2 time weekly, it is used in conjunction 3～5 weeks.The recovery of spinal function can be promoted.
Four, convalescent care
Start functional exercise the most as early as possible, note keeping limbs to be in functional position, with anti-affected limb contracture or deformity.
The patient that contracture or deformity have occurred the most should give physical therapy, physical exercise therapy etc., strengthens training further, maybe can give little dose
Amount is stable or trihexyphenidyl is administered orally, to alleviate muscular tension
Medical material involved in the present invention all seen from be recorded in " China book on Chinese herbal medicine ".
Summary of the invention
It is desirable to provide one is used for treating myelitic medicine, by selecting suitable medical material and proportioning thereof, reach
To safely and effectively curing myelitic purpose.
In order to achieve the above object, the present invention is by the following technical solutions:
One is used for treating myelitic medicine, it is characterised in that it is to be prepared from by the raw medicinal material of following weight proportion:
Rhizoma Polygonati Odorati 12 parts, Fructus Corni 7 parts, the Radix Astragali 12 parts, Semen Bauhiniae championii 10 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Flos Lonicerae maackii 12 parts, Caulis Trachelospermi 10 parts, south
Cortex Acanthopancis 8 parts.
Illustrate the method have the benefit that below in conjunction with theories of Chinese materia medica
It has been recognised by the inventors that myelitis is mainly due to the heresy of row epidemic disease poison during diseases caused by exogenous pathogenic factor, the thing of internal injury unhygienic diet, sick from mouth and nose people,
In addition ferritic posseses deficiency, and muscles and bones is weak, and healthy energy is not propped up, and causes the state of an illness to deepen continuously differentiations, and delay is difficult heals.Lung is burnt by fire, then
Water source exhausts absolutely, and taste are impaired, accumulates in the course of time into wet, strongly fragrant and heat-transformation, damp and hot transpiration, on smoke in lung, then the scorehed lung-lobe due to lung-heat is more very, golden dry water
Losing, exhaustion of kidney-YIN, the exhausted source of body fluid, muscle arteries and veins loses supports.Weakness of the spleen and stomach: malnutrition, lacks of proper care after one's birth, weakness of the spleen and stomach, biochemical not enough, gas
Anemia is empty, and Seasonal Evils is availed oneself of the opportunity to get in, and vital QI cannot conquer pathogen causes the state of an illness deeply to develop, in addition pathogenic heat impairing the spleen and stomach, and body fluid dries up,
Muscle arteries and veins loses to support and forms primary disease.Qi depression to blood stasis: Seasonal Evils is taken advantage of in void enters, and lies prostrate in meridians, and QI and blood is lost in smoothness, qi depression to blood stasis, warp
Arteries and veins blocks, and limbs lose supports.Deficiency of both the liver and kidney: liver storing blood and main muscle, moistens joint, deficiency of the liver then blood failing to nourish tendons, and profit is lost in joint；Kidney governing bones
Raw marrow, deficiency of the kidney and smart withered arteries and veins wither, it is difficult to cure.Therefore treat suitable nourishing YIN and moistening the lung, and liver and kidney tonifying, invigorating the spleen and benefiting QI, replenishing and activating blood,
Strong muscles and bones.
The present invention uses: Rhizoma Polygonati Odorati nourishing YIN and moistening the lung；Fructus Corni liver and kidney tonifying；Radix Astragali benefiting QI and nourishing blood；Semen Bauhiniae championii promoting the circulation of QI to relieve pain,
Blood circulation promoting and blood stasis dispelling；Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI；Flos Lonicerae maackii heat-clearing and toxic substances removing；Caulis Trachelospermi promoting blood circulation to remove obstruction in the collateral, removing toxic substances and promoting subsidence of swelling；CORTEX ACANTHOPANACIS tonifying liver
Kidney, bone and muscle strengthening, arteries and veins of invigorating blood circulation.All medicines share, and play nourishing YIN and moistening the lung altogether, liver and kidney tonifying, invigorating the spleen and benefiting QI, replenishing and activating blood, strong muscles and bones it
Effect.
Below in conjunction with clinical laboratory data beneficial effects of the present invention is described:
1, physical data
Inventor collects 64 example myelitis patients altogether between in November ,-2014 in May, 2012.It is randomly divided into: treatment group 32 example, comparison
Organize 32 examples.Male 21 examples of wherein treatment group, female 11 example, 18 to 34 years old ages, the course of disease 1～5 months；Matched group man 18 examples, female 14 example,
18 to 32 years old ages, the course of disease 1～6 months.The data such as two groups of sexes, age, courses of disease there was no significant difference, and has comparability.
Diagnostic criteria:
Sign:
1. the dyskinesia: mainly show as the upper motor neuron paralysis of below lesion segment.But Acute onset person, in early days
Can be transient flaccid paralysis, referred to as spinal shock.Engender tendon hyperreflexia after a few days to several weeks, hypermyotonia and
Typical case's sign such as pathologic reflex.The corresponding muscle of lesion segment shows as lower motor neuron property paralysis, but mostly without typical body
Levy.The dyskinesia is the most symmetrical, it is possible to involve side, or bilateral severity extent differs.If diseased region is higher, may occur in which breathing
Myoparalysis, dysphagia etc..
2. sensory disturbance: feel below lesion segment to go down or lose.Depth sensation all has gets involved in various degree, but bilateral
The order of severity is the most symmetrical.If only side spinal cord is got involved, then show as lesion levels following contralateral limbs pain, athalposis,
Homonymy deep sensory lacks.Normal and the Chang Youyi zone of hyperalgesia, anesthetic junctional area in sensation.
3. vegetative nerve symptom: there are urine retention or constipation acute stage more, engenders urinary incontinence, portion after the spinal shock phase
Point case eventually becomes autonomous bladder.With the difference of infringement sections, may occur in which other plant delayed ischemic neurological deficits, such as Horner
Syndrome, vasomotion exception, sweat secretion and malnutrition and viscera function exception etc..
Laboratory diagnosis
Blood: leukocyte counts normally or slightly increases.Cerebrospinal fluid: cerebrospinal pressure is the highest.Seen from cerebrospinal fluid in vain
Cell.Protein content normally or slightly increases.Sugar and chloride content are normal.Typically block phenomenon without canalis spinalis.Single cases can
Substantially spinal cavity partial outlet obstruction occurs because pathological changes position water is swollen.
Inclusive criteria: 1. meet diagnostic criteria；2. age less than 70 years old；3. compliance is good；Sign informed consent the most voluntarily
Book.
Exclusion standard: 1. suffer from severe cardiac, lung, liver, renal disease patient；2. there are other psychosis, it is impossible to join
Close therapist；3. through the patient of other drug treatment after morbidity.
2, Therapeutic Method
Treatment group is administered orally the capsule that the present invention prepares according to specific embodiment 3, three times a day.Treat 2 weeks.
Matched group gives traditional dexamethasone and is administered orally: 0.75mg/d.Treat 2 weeks.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Effective: serious lower extremity paralysis patient can walk about down, defecation of urinating recovers normal, substantially can recover normal
Life.
Effective: myodynamia is obviously improved, urinate normal, can walk voluntarily.
Invalid: before and after treatment, there is no significant change
3.2 treatment statistical results are shown in Table 1.
1 liang of table group comparitive study
| Group | n | Effective | Effectively | Invalid | Total effective rate (%) | Obvious adverse reaction example |
| Treatment group | 32 | 14 | 15 | 3 | 91% | 0 |
| Matched group | 32 | 10 | 14 | 8 | 75% | 0 |
Visible, myelitis can safely and effectively be treated by the medicine that the present invention prepares, and cure rate is high.
Detailed description of the invention
In order to be more fully understood that and implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Embodiment 1
Weigh: Rhizoma Polygonati Odorati 12 grams, Fructus Corni 7 grams, the Radix Astragali 12 grams, Semen Bauhiniae championii 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Flos Lonicerae maackii 12 grams, trachelospermum jasminoide
10 grams of rattan, CORTEX ACANTHOPANACIS 8 grams；Add 8 times amount water, decoct 1.5 hours, filter；Filtering residue adds 6 times amount water, decocts 1 hour, filters；Close
And filtrate, it is concentrated into 120 grams, the decoct of one day consumption of adult normal must be met.
For treating myelitis.Oral, the most once.
Embodiment 2
Weigh: Rhizoma Polygonati Odorati 12 grams, Fructus Corni 7 grams, the Radix Astragali 12 grams, Semen Bauhiniae championii 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Flos Lonicerae maackii 12 grams, trachelospermum jasminoide
10 grams of rattan, CORTEX ACANTHOPANACIS 8 grams；Add 10 times amount water, decoct 2 hours, filter；Filtering residue adds 8 times amount water, decocts 1.5 hours, filters；
Merging filtrate, concentrates, and is dried, and packaging must meet the powder of one day consumption of adult normal.
For treating myelitis.Oral, every bu is taken for twice sooner or later.
Embodiment 3
Weigh: Rhizoma Polygonati Odorati 12 grams, Fructus Corni 7 grams, the Radix Astragali 12 grams, Semen Bauhiniae championii 10 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Flos Lonicerae maackii 12 grams, trachelospermum jasminoide
10 grams of rattan, CORTEX ACANTHOPANACIS 8 grams；Add 6 times amount water, decoct 3 times, decoct 1 hour every time, merge decoction liquor, concentrate, be dried, load
Capsule shells, must meet the capsule of one day consumption of adult normal.
For treating myelitis.Oral, every bu morning, noon and afternoon take for three times.
Claims (4)
1. one kind is used for treating myelitic medicine, it is characterised in that it is by the raw medicinal material preparation of following weight proportion
Become: Rhizoma Polygonati Odorati 12 parts, Fructus Corni 7 parts, the Radix Astragali 12 parts, Semen Bauhiniae championii 10 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Flos Lonicerae maackii 12 parts, Caulis Trachelospermi 10 parts,
CORTEX ACANTHOPANACIS 8 parts.
It is used for the most as claimed in claim 1 treating myelitic medicine, it is characterised in that its preparation method is: weigh: Rhizoma Polygonati Odorati
12 parts, Fructus Corni 7 parts, the Radix Astragali 12 parts, Semen Bauhiniae championii 10 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Flos Lonicerae maackii 12 parts, Caulis Trachelospermi 10 parts, south Acanthopanax gracilistylus
Skin 8 parts；Add 8 times amount water, decoct 1.5 hours, filter；Filtering residue adds 6 times amount water, decocts 1 hour, filters；Merging filtrate, is concentrated into
120 parts, obtain decoct；Above-mentioned part each means weight portion.
It is used for the most as claimed in claim 1 treating myelitic medicine, it is characterised in that its preparation method is: weigh: Rhizoma Polygonati Odorati
12 parts, Fructus Corni 7 parts, the Radix Astragali 12 parts, Semen Bauhiniae championii 10 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Flos Lonicerae maackii 12 parts, Caulis Trachelospermi 10 parts, south Acanthopanax gracilistylus
Skin 8 parts；Add 10 times amount water, decoct 2 hours, filter；Filtering residue adds 8 times amount water, decocts 1.5 hours, filters；Merging filtrate, concentrates,
It is dried, packaging, obtains powder；Above-mentioned part each means weight portion.
It is used for the most as claimed in claim 1 treating myelitic medicine, it is characterised in that its preparation method is: weigh: Rhizoma Polygonati Odorati
12 parts, Fructus Corni 7 parts, the Radix Astragali 12 parts, Semen Bauhiniae championii 10 parts, the Rhizoma Atractylodis Macrocephalae 10 parts, Flos Lonicerae maackii 12 parts, Caulis Trachelospermi 10 parts, south Acanthopanax gracilistylus
Skin 8 parts；Add 6 times amount water, decoct 3 times, decoct 1 hour every time, merge decoction liquor, concentrate, be dried, load capsule shells, obtain glue
Wafer；Above-mentioned part each means weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610661145.5A CN106138712A (en) | 2016-08-13 | 2016-08-13 | One is used for treating myelitic medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610661145.5A CN106138712A (en) | 2016-08-13 | 2016-08-13 | One is used for treating myelitic medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106138712A true CN106138712A (en) | 2016-11-23 |
Family
ID=57329890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610661145.5A Pending CN106138712A (en) | 2016-08-13 | 2016-08-13 | One is used for treating myelitic medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106138712A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101002910A (en) * | 2006-12-29 | 2007-07-25 | 周德超 | Traditional Chinese medicine for treating bone medullitis |
| CN105056186A (en) * | 2015-08-12 | 2015-11-18 | 鄢明亮 | Application of medicine composition in preparation of medicines for treating cerebral arteriosclerosis and myelitis |
| CN105596973A (en) * | 2015-10-09 | 2016-05-25 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating acute myelitis |
| CN105687656A (en) * | 2016-02-18 | 2016-06-22 | 朱拥军 | Pharmaceutical composition for treating myelitis and preparation method thereof |
-
2016
- 2016-08-13 CN CN201610661145.5A patent/CN106138712A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101002910A (en) * | 2006-12-29 | 2007-07-25 | 周德超 | Traditional Chinese medicine for treating bone medullitis |
| CN105056186A (en) * | 2015-08-12 | 2015-11-18 | 鄢明亮 | Application of medicine composition in preparation of medicines for treating cerebral arteriosclerosis and myelitis |
| CN105596973A (en) * | 2015-10-09 | 2016-05-25 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating acute myelitis |
| CN105687656A (en) * | 2016-02-18 | 2016-06-22 | 朱拥军 | Pharmaceutical composition for treating myelitis and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102727781A (en) | Traditional Chinese medicine composition for treating lumbago | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN104491675B (en) | Huoxue Huayu Decoction | |
| CN104324340B (en) | It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof | |
| CN106039245A (en) | External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof | |
| CN1977899A (en) | Medicine for treating rheumatoid arthritis | |
| CN102600272B (en) | Traditional Chinese medicine for treatment of orthopedic disease | |
| CN104587252A (en) | Traditional Chinese medicine composition for treating kidney stones | |
| CN104707025A (en) | Traditional Chinese medicine composition for treating chronic appendicitis | |
| CN106620604A (en) | Navel moxibustion traditional Chinese medicine composition for treating chronic diarrhea as well as preparation method and application thereof | |
| CN105853969A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof | |
| CN106110124A (en) | A kind of antituberculotic Chinese medicine composition | |
| CN106138712A (en) | One is used for treating myelitic medicine | |
| CN104771734B (en) | A kind of Chinese medicine composition for treating chronic cardiopulmonary disease | |
| CN109731047A (en) | It is a kind of to treat disc herniation, osteoproliferation, rheumatism numbness pain, the arthralgia and myalgia cream of neck-shoulder pain, lumbago and leg pain and preparation method | |
| CN104352700B (en) | A kind of Chinese medicine composition for treating protrusion of lumber intervertebral disc | |
| CN102988952A (en) | Umbilicus-applied nursing cream for preventing uroschesis of infant accepting surgical operation | |
| CN102784376B (en) | Preparation method of traditional Chinese medicine for treating anorexia type acute glomerulonephritis | |
| CN102793903B (en) | Preparation method of Chinese medicament for treating kidney-yang deficiency type acute glomerulonephritis | |
| CN100337652C (en) | Chinese medicinal decoction for preventing and treating cancer | |
| CN107158265A (en) | A kind of Chinese medicine composition for treating the prolapse of uterus | |
| CN101244181A (en) | Plaster for bone paralysis with function of qufengshengshi, blood circulation activating and stasis removing, and removing the obstruction in the channels to relieve pain, and preparation thereof | |
| CN106511696A (en) | Soup for invigorating kidney, reinforcing tendon and strengthening waist | |
| CN105687392A (en) | Blood-activating and collateral-dredging wine and preparation method thereof | |
| CN105770834B (en) | A kind of Chinese medicinal pill for treating polymyalgia rheumatica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161123 |